Skip to main content

Part of the book series: Advances in Pharmacological Sciences ((APS))

Summary

Nicotine has been found by many but not all studies to improve and mecamylamine to impair performance on cognitive tasks in humans and experimental animals. In our laboratory, a very reproducible finding has been that chronic infusion of nicotine significantly improves memory performance in a win-shift version of the radial-arm maze. Nicotine attenuates the memory deficits caused by lesions of the fimbria-fornix or the medial basalocortical projection. Chronic co-administration of the nicotinic antagonist mecamylamine eliminates the nicotine effect. Some aspects of the cognitive deficit in Alzheimer’s disease are attenuated by nicotine, suggesting promise for the therapeutic use of nicotine or other nicotinic ligands for cognitive dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Warburton DM.: Nicotine as a cognitive enhancer. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 1992; 16: 181–919.

    CAS  Google Scholar 

  2. Warburton DM, Wesnes K.: Mechanisms for habitual substance use: Food, alcohol and cigarettes. In: Gale A, Edwards JA eds., Physiological Correlates of Human Behaviour, Vol. I: Basic Issues, London, Academic Press, 1984: 277–297.

    Google Scholar 

  3. Wesnes K, Warburton DM.: Smoking, nicotine and human performance. Pharmacol. Ther. 1983; 21: 189–208.

    Article  PubMed  CAS  Google Scholar 

  4. Heishman SJ, Snyder FR, Henningfield JE.: Effect of repeated nicotine administration in nonsmokers. NIDA research 1991; series 105: 314–315.

    Google Scholar 

  5. Levin E.: Nicotinic systems and cognitive function. Psychopharmacology 1992; 108: 417–431.

    Article  PubMed  CAS  Google Scholar 

  6. Roth N, Lutiger B, Hasenfratz M, Bättig K, Knye M.: Smoking deprivation in “early” and “late” smokers and memory function. Psychopharmacology 1992; 106: 253–260.

    Article  PubMed  CAS  Google Scholar 

  7. Levin ED, Rose JE.: Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 1991; 27: 125–128.

    Article  PubMed  CAS  Google Scholar 

  8. Levin ED, Rose JE, Abood L.: Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmacol. Biochem. Behay. 1994; submitted.

    Google Scholar 

  9. Brucato FH, Levin ED, Rose JE, Swartzwelder HS.: Interocerebroventricular nicotine and mecamylamine alters radial-arm maze performance in rats. Drug Dev. Res. 1994; 31: 18–23.

    Article  CAS  Google Scholar 

  10. Levin ED, Briggs SJ, Christopher NC, Auman JT.: Working memory performance and cholinergie effects in the ventral tegmental area and substantia nigra. Brain Res. 1994; in press.

    Google Scholar 

  11. Levin ED, Rose JE.: Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. Behay. Pharmacol. 1990; 1: 511–520.

    Google Scholar 

  12. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jaravik M, Gritz E.: Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behay. Neural. Biol. 1990; 53: 269–276.

    Article  CAS  Google Scholar 

  13. Levin ED, Briggs SJ, Christopher NC, Rose JE.: Chronic nicotinic stimulation and blockade effects on working memory. Behay. Pharmacol. 1993; 4: 179–182.

    Article  CAS  Google Scholar 

  14. Levin ED, Christopher NC, Briggs SJ, Rose JE.: Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cog. Brain Res. 1993; 1: 137–143.

    Article  CAS  Google Scholar 

  15. Levin ED, Christopher NC, Briggs SJ.: Comparison of chronic nicotine and mecamylamine effects on working memory performance in the radial-arm maze and T-maze alternation. Soc Neurosci Abs 1994; in press.

    Google Scholar 

  16. Levin ED, Rose JE.: Acute and chronic nicotinic interactions with dopamine systems and working memory performance. In: Lajtha A, Abood L eds., Functional Diversity of Interacting Receptors, New York:The New York Academy of Sciences, 1994, in press.

    Google Scholar 

  17. Levin ED, Briggs SJ, Christopher NC, Rose JE.: Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol 1992; 58: 152–158.

    Article  PubMed  CAS  Google Scholar 

  18. Dunnett SB, Martel FL.: Proactive interference effects on short-term memory in rats: 1. Basic parameters and drug effects. Behay. Neurosci. 1990; 104: 655–665.

    Article  CAS  Google Scholar 

  19. Moran PM.: Differential effects of scopolamine and mecamylamine on working and reference memory in the rat. Pharmacol Biochem Behav 1993; 45: 533–538.

    Article  PubMed  CAS  Google Scholar 

  20. Decker MW, Majchrzak MJ.: Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotine cholinergic antagonist, on spatial memory in rats. Psychopharmacology 1992; 107: 530–534.

    Article  PubMed  CAS  Google Scholar 

  21. Ohno M, Yamamoto T, Watanabe S.: Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol Biochem Behav 1993; 45: 89–93.

    Article  PubMed  CAS  Google Scholar 

  22. Blozovski D.: Deficits in passive avoidance learning in young rats following mecamylamine injections in the hippocampo-entorhinal area. Exp. Brain Res. 1983; 50: 442–448.

    Article  PubMed  CAS  Google Scholar 

  23. Blozovski D, Dumery V.: Development of amygdaloid choinergic mediation of passive avoidance learning in the rat. Exp. Brain. Res. 1987; 67: 70–76.

    Article  PubMed  CAS  Google Scholar 

  24. Stolerman IP, Goldfarb T, Fink R, Jarvik ME.: Influencing cigarette smoking with nicotine antagonists. Psychopharmacology 1973; 28: 247–259.

    Article  CAS  Google Scholar 

  25. Newhouse PA, Potter A, Corwin J, Lenox R.: Modeling the nicotinic receptor loss in dementia using the nicotinic antagonist mecamylamine: Effects on human cognitive functioning. Drug Dev. Res. 1994; 31: 71–79.

    Article  CAS  Google Scholar 

  26. McGurk SR, Levin ED, Butcher LL.: Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic drugs. Psychopharmacology 1989; 99: 371–373.

    Article  PubMed  CAS  Google Scholar 

  27. Levin ED, McGurk SR, Rose JE, Butcher LL.: Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555. Pharmacol. Biochem. Behay. 1989; 33: 919–922.

    Article  CAS  Google Scholar 

  28. Levin ED.: Scopolamine interactions with D, and D2 antagonists on radial-arm maze performance in rats. Behav Neural Biol 1988; 50: 240–245.

    Article  PubMed  CAS  Google Scholar 

  29. Levin ED.: Interactive effects of nicotinic and muscarinic agonists with the dopaminergic agonist pergolide on rats in the radial-arm maze. In preparation 1994.

    Google Scholar 

  30. Levin ED, Eisner B.: Nicotine interactions with D, and D2 agonists: Effects on working memory function. Drug Dev. Res. 1994; 31: 32–37.

    Article  CAS  Google Scholar 

  31. Widzowski DV, Cregan E, Bialobok P.: Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats. Drug Dev. Res. 1994; 31: 24–31.

    Article  CAS  Google Scholar 

  32. Buccafusco JJ, Jackson WJ.: Beneficial effects of nicotine administered prior to a delayed matching-tosample task in young and aged monkeys. Neurobiol. Aging 1991; 12: 233–238.

    Article  PubMed  CAS  Google Scholar 

  33. Hodges H, Gray JA, Allen Y, Sinden J.: The role of the forebrain cholinergic projection system in performance in the radial-arm maze in memory-impaired rats. In: Adlkofer F, Thurau K eds., Effects of Nicotine on Biological Systems, Basel: Birkhäuser Verlag, 1991: 389–399.

    Chapter  Google Scholar 

  34. Tilson HA, McLamb RL, Shaw S, Rogers BC, Pediatikakis P, Cook L.: Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agonists. Brain Res 1988; 438: 83–94.

    Article  PubMed  CAS  Google Scholar 

  35. Decker MW, Majchrzak MJ, Anderson DJ.: Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res. 1992; 572: 281–285.

    Article  PubMed  CAS  Google Scholar 

  36. Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA.: Nicotine as a tool to characterise the role of the forebrain cholinergie projection system in cognition. In: Lippiello PM, Collins AC, Gray JA, Robinson JH eds., The Biology of Nicotine: Current Research Issues, New York: Raven Press, 1992: 157–182.

    Google Scholar 

  37. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL.: Intravenous nicotine in Alzheimer’s disease: A pilot study. Psychopharmacology 1988; 95: 171–175.

    Article  PubMed  CAS  Google Scholar 

  38. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA.: Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer’s disease. Psychopharmacology 1992; 108: 485–494.

    Article  PubMed  CAS  Google Scholar 

  39. Sahakian B, Jones G, Levy R, Gray J, Warburton D.: The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br. J. Psychiat. 1989; 154: 797–800.

    Article  CAS  Google Scholar 

  40. Kellar KJ, Wonnacott S.: Nicotinic cholinergic receptors in Alzheimer’s disease. In: Wonnacott S, Russell MAH, Stolerman IP eds., Nicotine Psychopharmacology: Molecular, Cellular, and Behavioral Aspects„ Oxford: Oxford University Press, 1990: 341–373.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Birkhäuser Verlag Basel

About this chapter

Cite this chapter

Levin, E.D., Tony, D. (1995). Nicotine Effects on Memory Performance. In: Clarke, P.B.S., Quik, M., Adlkofer, F., Thurau, K. (eds) Effects of Nicotine on Biological Systems II. Advances in Pharmacological Sciences. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7445-8_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7445-8_43

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7447-2

  • Online ISBN: 978-3-0348-7445-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics